A mediation model to explain HIV antiretroviral adherence among gay and bisexual men

Journal of Gay and Lesbian Social Services

Volumn 19, Issue 1, 2007, Pages 35-55

  Halkitis, Perry N ^a   Palamar, Joseph ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Adherence; Gay; HIV; Latent class analysis; SEM; Treatment

Indexed keywords

EID: 42649135945     PISSN: 10538720     EISSN: 15404056     Source Type: Journal    
DOI: 10.1300/J041v19n01_03     Document Type: Article

References (63)

1. Addiction Research Foundation (1982). Drug Abuse Screening Test (DAST-10). Toronto, Canada.
2. Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., et al. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndrome, 15, 445-449.
3. Bangsberg, D.R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodiny, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
4. Batki, S.L., & Ferrando, S.J. (1996). Diagnosis and treatment of substance use disorders in patients with HIV infection. International Review of Psychiatry, 8, 242-252.
5. Beck, A. T., Ward, C. H., Mendeson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 562-571.
6. Blackwell, B. (1973). Drug therapy: Patient compliance. New England Journal of Medicine, 289, 249-252.
7. Bondi, M.W., Drake, A.I., & Grand, I. (1998). Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse. Journal of the International Neuropsychological Society, 4, 319-328.
8. Bybee, J.A., & Ziegler, E. (1997). Self-image and guilt: A further test of the cognitive-developmental formulation. Journal of Personality 59, 733-745.
9. Carthew, D., & Styres, K. (1993). The effect of homelessness on compliance with medical regimens. Nurse Practitioner, 18, 8-11.
10. Center for Disease Control. (2003). Increases in HIV diagnoses - 29 States, 1999 - Morbidity and Mortality Weekly Report, 52, 1145-1148.
11. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care & STDs, 17, 169-177.
12. Cocco, K. M., & Carey, K. B. (1998). Psychometric properties of the drug abuse screening test in psychiatric outpatients. Psychological Assessment, 10(4), 408-414.
13. Crystal, S., Sambamoorthi, U., Moynihan, P.J., & McSpiritt, A. (2001). Initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS. Journal of General Internal Medicine 16, 850-859.
14. Cunningham, W.E., Andersen, R.M., Katz, M. H., Stein, M.D., Turner, B. J., Crystal, S., et al. (1999). The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Medical Care, 37, 1270-1281.
15. Demas, P., Schoenbaum, E.E., Hirky, A.E., Wills, T.A., Doll, L.S., Hartel, D.M., et al., (1998). The relationship of HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS and Behavior, 2, 283-292.
16. Eldred, L., Wu, A., Chaisson, R. E., & Moore, R.D. (1997). Adherence to antiretroviral therapy in HIV disease. Paper presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC.
17. Fisher, J.D., Cornman, D.H., Osborn, C.Y., Rivet Amico, K., Fisher, W.A., & Friedland, G.A. (2004). Clinician initiated HIV risk reduction intervention for HIV-positive personals. Journal of Acquired Immune Deficiency Syndrome, 37 (Suppl. 2), SS78-S87.
18. Folkman, S., Chesney, J., Pollack, L., & Coates, T. (1993). Stress, control, coping, and depressive mood in human immunodeficiency virus-positive and-negative gay men in San Francisco. Journal of Nervous and Mental Disease, 181, 409-416.
19. Freeman, R. C., Rodriguez, G. M., & French, J. F. (1996). Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue. AIDS Education & Prevention, 8, 58-71.
20. Greenberg, B., McCorkle, R., Vlahov, D., & Selwyn, P. A. (2000). Palliative care for HIV disease in the era of highly active antiretroviral therapy. Journal of Urban Health, 77, 150-65.
21. Grossberg, R., Zhang, Y., & Gross, R. (2004). A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57, 1107-1110.
22. Halkitis, P. N., & Kirton, C. (1999). Self-strategies as means of enhancing adherence to HIV antiretroviral therapies: A Rogerian approach. Journal of the New York State Nurses Association, 14, 1-5
23. Halkitis, P. N., Kutnick, A. H., Parsons, J. P., & Slater, S. (In Press). The social realities of adherence to protease inhibitor regimens: Substance use, health care, & psychological states. Journal of Health Psychology.
24. Halkitis, P. N., Kutnick, A. H., Rosof, E., Slater, S., & Parsons, J. P. (2003). Adherence to HIV medications in a cohort of men who have sex with men: Impact of September 11th. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80(1), 161-166.
25. Halkitis, P.N., Parsons, J.T., Wolitski, R., & Remien, R.H. (2003). Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, 89-102.
26. Haubrich, R., Little, S., Dube, M., Forthal, D., Beall, G., Kemper, C., et al. (1998, June). Self reported treatment adherence and drug/ alcohol use are associated with virologic outcomes in CCTG 570: A clinical strategy trial of HIV RNA antiretroviral (ARV) monitoring. Poster presented at the 12th World AIDS Conference, Geneva, Switzerland.
27. Haynes R.B. (1979). Compliance in health care. Baltimore, MD: Johns Hopkins University Press.
28. Hecht, F., Kahn, K.B., Dillon, B., Chesney, M., & Grant, R.M. (1998, June). Transmission of protease inhibitor resistant HIV-1 to a recently infected antiretroviral-naive man: The UCSF primary HIV project Paper presented at the 12th World AIDS Conference, Geneva, Switzerland.
29. Hirschhorn, L., Quinones, J., Goldin, S., & Metras, L. (1998, June). Highly active anti-Retroviral therapy (HAART) in the "Real World": Experiences in an inner-city community health center (CHC). Poster presented at the 12th World AIDS Conference, Geneva, Switzerland.
30. Ho, D.D., Neuman, A.U., Perelson, A.S., Chen, W., Leonard, J.M., & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV- 1 infection. Nature, 373, 123-126.
31. Joreskog, K. & Sorbom, D. (1997). LISREL 8: User's reference guide. Scientific Software Inc.: Lincolnwood, IL.
32. Kalichman, S.C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91, 439-446.
33. Kappes, J.C., Saag, M.S., Shaw, G.M., Hahn, B.H., Chopra, P., Chen, S., et al. (1995). Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV- 1 antigen and viral RNA (QC-PCR) assays compared. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 10, 139-149.
34. Kastrissios, H., Suarez, J.R., Katzenstein, D., Girard, P., Sheiner, L.B., & Blaschke, T. F. (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS, 12, 2295-2303.
35. Kennedy, S. B. (2000). Developing a self-administered tool to predict adherence to antiretroviral therapy: Design, method, and objectives. AIDS Patient Care & STDs, 14, 309-316.
36. Kleeberger, C. A., Phair, J. P., Strathdee, S. A., Detels, R., Kingsley, L., & Jacobson, L. P. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndrome, 26, 82-92.
37. Kruse, W., Rampmaier, J., Ullrich, G., & Weber, E. (1994). Patterns of drug compliance with medication to be taken once and twice daily assessed by continuous electronic monitoring in primary care. International Journal of Clinical Pharmacology Therapy, 32, 453-457.
38. Liu, H., Golin, C.E., Miller, L.G., Hays, R.D., Beck, K.C., & Sanandaji, S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
39. Low-Beer, S., Yip, B., O'Shaughnessy, M.V., Hogg, R.S., & Montaner, J.S.G. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23, 360-361.
40. Lucas, G.M., Gebo, K.A., Chaisson, R.E., & Moore, R.D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV- 1 treatment outcomes in an urban clinic. AIDS, 16, 767-774.
41. Martini, M., Recchia, E., Nasta, P., Castanatto, D., Chiaffarino, F., Parazzini, I., et al. (2004). Illicit drug use: Can it predict adherence to antiretroviral therapy. European Journal of Epidemiology, 19, 585-587.
42. Matsuyama, J.R., Mason, B.J., & Jue, S.G. (1995). Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Annals of Pharmacotherapy, 27, 851-855.
43. Mehta S., Moore R.D., & Graham, N. M. H. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
44. Miller, W.R., & Rollnick, S. (2002). Motivational interviewing; Preparing people for change (2nd ed.). New York, NY: Guilford Press.
45. Montaner, J. S., Harris, M., Mo, T., & Harrigan, P. R. (1998). Rebound of plasma HIV viral load following prolonged suppression with combination therapy. AIDS, 12, 1398-1399.
46. Morse, E.V., Simon, P.M., Coburn, M., Hyslop, N., Greenspan, D., & Balson, P. M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science & Medicine, 32, 1161-1167.
47. Moustaki, I., Jöreskog, K. G., & Mavridis, D. (2004). Factor models for ordinal variables with covariate effects on the manifest and latent variables: A comparison of LISREL and IRT approaches. Structural Equation Modeling, 11(4), 487-513.
48. Patterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squire, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 133, 21-30.
49. Roland, M. (1998). Antiviral adherence dilemmas. Focus: A guide to AIDS research and Counseling, 13, 1-4.
50. Rosseli, M., & Ardila, A. (1996). Cognitive effects of cocaine and polydrug abuse. Journal of Clinical & Experimental Neuropsychology 18, 122-135.
51. Routy, J.P., Brenner, B., Salomon, H., Quan, Y., Campos, A.F., Rouleau, D., et al. (2000). Transmission of dual and triple-class drug resistant vital variants in primary/early HIV-1 infection (PHI) in Montreal. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.
52. Sackett, D., Haynes, R.B., & Taylor, D.W. (1979). Compliance in health care. Baltimore, MD: Johns Hopkins University Press.
53. Shidlo, A. (1994). Internalized Homophobia: Conceptual and Empirical Issues in Measurement. In B. Green, & G. Herek, (Eds.), Psychological Perspectives on L & H. Issues: Theory Research and Clinical Applications Thousand Oaks, CA: Sage.
54. Singer, M. (1994). AIDS and the health crisis of the U.S. urban poor: The perspective of critical medical anthropology. Social Science & Medicine, 39, 931-948.
55. Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M.H., & Yu, V.L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
56. Stein, J. A., & Nyamathi, A. (1999). Gender differences in relationships among stress, coping, and health risk behaviors in impoverished, minority populations. Personality & Individual Differences, 26, 141-157.
57. Stone, V.E., Adelson-Mitty, J., Arnsten, J.H., Davenny, K., & Schoenbaum, E.E. (2002). What strategies do providers use to enhance adherence to HAART? AIDS & Public Policy Journal, 11, 66-77.
58. Turner, C.F., Ku, L., Rogers, S.M., Lindberg, L.D., Pleck, J.H., & Sonerstein, F.L. (1998). Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science, 280, 867-873.
59. Wagner, G. J., & Ryan, G. W. (2004). Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care & STDS, 18, 385-393.
60. Wainberg, M.A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1980.
61. Waterhouse, D. M., Calzone, K.A., Mele, C., & Brenner, D.E. (1993). Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology 11, 1189-1197.
62. Watters, J.K., & Biernacki, P. (1989). Targeted sampling: Options and considerations for the study of hidden populations. Social Problems 36, 416-430.
63. Weiser, S. D., Wolfe, W. R., & Bangsberg, D. R. (2004). HIV epidemic among individuals with mental illness in the United States. Current Infectious Disease Report, 6, 404-410.